Andrew Feilden

Andrew Feilden, Bicycle Therapeutics - Qepler Summits And Conferences

Andrew Feilden

Director Analytical Sciences
Bicycle Therapeutics
Shawbury, United Kingdom
Bicycle Therapeutics

Dr. Andrew Feilden is the European E&L strategic Director at Hall Analytical.

Prior to that he was the Chemistry Operations Director, for 6 years, where he lead the chemistry group at the Shawbury site in the UK. The Shawbury site carries out extractable and leachable testing, GPC analysis and food contact testing. He has delivered numerous international podium presentations on Extractables and leachables.

Andrew has been with Smithers for over 7 years, prior to that he worked for AstraZeneca, specialising in Extractables and Leachables.

He has a degree and D Phil from the university of York, is a Fellow of the Royal Society of Chemistry and is a Scientific advisor to IPAC-RS

Related Sessions:

Qepler - Inhaled Drug Delivery Summit thumbnail Details

Inhaled Drug Delivery
Summit 2019

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 23 May 2019
  • Berlin, DE
  • Pharma
Day 2: Friday, 24 May 2019
BLOCK: ANALYTICAL APPROACHES & SPECIFICATIONS.
CASE STUDY: Material selection for OINDPs (orally inhaled and nasal drug products).
  • Types of materials
  • Priorities for selecting materials
    • Physical vs chemical vs chemical vs change management
  • Risk Management for materials and components
View Details
Qepler - Genotoxic Impurities in Pharmaceuticals Summit thumbnail Details

Genotoxic Impurities in
Pharmaceuticals Summit 2019

GTI strategies & new methodologies: analysis, in silico & regulations. Challenges & opportunities.
  • 11 Apr 2019
  • Berlin, DE
  • Pharma
Day 1: Thursday, 11 April 2019
CASE STUDY: ICH M7 and extractables & leachables: understanding control, analysis and regulations of E&L.
  • What are extractables and leachables
  • What are the similarities and differences between E and L and genotoxic impurities
  • What are the regulations that are applicable, specifically M7
View Details
Qepler - 2nd Annual Inhaled Drug Delivery Virtual Summit thumbnail Details

2nd Annual Inhaled
Drug Delivery Summit 2021

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 05 Aug 2021
  • Virtual,
  • Pharma
Day 1: Thursday, 05 August 2021
CASE STUDY: Understanding of regulations and requirements for OINDPs.
  • Overview of E&L for OINDPs
  • What are Extractables and leachables
  • Why most important for OINDPs
  • Brief over view of regulations
  • Case studies
View Details
Qepler - 2nd Annual Extractables & Leachables Summit thumbnail Details

2nd Annual Extractables &
Leachables Summit 2020

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 22 Oct 2020
  • Virtual,
  • Pharma
Day 2: Friday, 23 October 2020
CASE STUDY: Similarities and differences between medicinal products and medical devices for Extractable and leachable testing.
  • What are Medical devices and Medical products Regulatory expectations
  • Similarities and differences between medicinal products and medical devices for Extractable and leachable testing
View Details
Qepler - 3rd Annual Extractables & Leachables Summit thumbnail Details

3rd Annual Extractables &
Leachables Summit 2023

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 11 Oct 2023
  • Virtual,
  • Pharma
Day 1: Wednesday, 11 October 2023
CASE STUDY: Extractable and leachables challenges and issues with Biologicals
  • Why are large molecules of more concern
  • Challenges of highly hazardous APIs
  • Interaction of biologicals with leachables
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.